Anxiety

Compared with other hospital patients, those with COVID-19 reported greater anxiety and perceived trauma, according to findings published in BMC Psychiatry.

Brigitte Schiller, MD, FACP, FASN, has joined the global medical office of Fresenius Medical Care to support its care enablement efforts in home dialysis, according to a press release.

Prevalence of depressive and anxiety disorders, as well as related symptoms, was greater in patients with alopecia areata compared with the general population, according to a study.

Patients with juvenile idiopathic arthritis do not appear to have an increased risk for anxiety or depression, compared with the general population, according to data published in Pediatric Rheumatology.

Long-term joint exposure to multiple air pollutants at low concentrations may be associated with an increased risk of depression and anxiety, according to a study published in JAMA Psychiatry.

Transgender and nonbinary youths had greater appearance congruence — the experience that physical appearance aligns with gender —and less depression and anxiety after 2 years of gender-affirming hormone therapy, according to study data.

Biopharmaceutical company Karuna Therapeutics has announced an exclusive license agreement with biotech firm Goldfinch Bio for its investigational transient receptor potential canonical 4 and 5 channel candidates, including GFB-887.

With a rising number of clinical studies demonstrating the potential benefits of psychedelic treatments for a wide range of behavioral health conditions, insurance plan provider Enthea aims to expand employer funding for these services.

A California-based biopharmaceutical company has announced the completion of its acquisition of Pherin Pharmaceuticals Inc., a drug development firm that specializes in neuropsychiatric and neuroendocrine issues.

U.S. physicians experienced more burnout and work-related stress in 2022 than in 2021, according to a recent survey.